latest news on glp 1 Lilly is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating A wave of new #GLP1

Off-Label Use: A Growing Concern GLP-1s approved for T2D are frequently used off-label for weight loss, raising concerns among both employers and health plans

Horlocker TT, Vandermeuelen E, Kopp SL, et al

Instead of synthetic hormones or harsh stimulants, it emphasizes GLP-1 pathways, which are now a central focus in both medical and nutritional weight management

Trout says

The reduction in MACE observed in treatment with GLP-1RAs is mainly driven by a significant reduction in fatal or non-fatal stroke, but also a significant reduction in risks for CV death and fatal or non-fatal myocardial infarction (15), suggesting that GLP-1RAs may exert their cardioprotective effects through anti-atherosclerotic mechanisms